A New York group is expected to announce Wednesday that it has filed challenges to patents on Sovaldi in Argentina, Brazil, China, ...http://www.nytimes.com/2015/05/20/business/high-cost-of-hepatitis-c-drug-prompts-a-call-to-void-its-patents.html?partner=rssnyt&emc=rss